Cholesterol test system recalled due to calibration failure
RANDOX CHOL cholesterol test system is recalled due to a calibration defect that causes quality control results to be flagged as out of range. This could result in inaccurate cholesterol measurements in patient samples.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II medical device recall involving a calibration defect that affects test accuracy. While no illnesses or injuries are reported in the source, the device provides inaccurate measurements that could lead to misdiagnosis and improper patient treatment—a risk-of-harm scenario where injury has not yet been documented.
Plain-English summary
The U.S. Food and Drug Administration is notifying users of a recall of the RANDOX CHOL cholesterol test system (Reference CH200), intended for measuring total cholesterol in blood plasma and serum samples. Two lot numbers are affected: 559344 (expiration 28th June 2022) and 572730 (expiration 28th July 2023). The product was distributed nationwide to laboratories and medical facilities in Georgia, Oregon, Pennsylvania, Washington, and West Virginia.
The test system is being recalled because of a calibration defect. When calibrating with the standard provided in the kit, the change in absorbance is lower than expected, causing the internal quality control results to be flagged as high and outside the acceptable range. A calibration failure of this nature can compromise the accuracy of cholesterol measurements.
Laboratories and medical facilities that received this product should immediately discontinue use and contact Randox Laboratories Ltd. for instructions regarding return or replacement of affected test kits.
The recalled product
- Product
- RANDOX CHOL-cholesterol (total) test system intended to measure cholesterol in plasma and serum REF: CH200
- Manufacturer
- Randox Laboratories Ltd.
- Affected units
- 15
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot Numbers/Exp Date: 559344 28th June 2022
- 572730 28th July 2023. GTIN: 05055273201130
Distribution
Related recalls
Same manufacturer · Randox Laboratories Ltd.
See all →- ModerateCystatin C Diagnostic Reagent Marketed Without FDA 510(k) Clearance
FDA (Devices) · 2024-07-31
- ModerateEvidence MultiSTAT analyzer foam gasket malfunction may affect test accuracy
FDA (Devices) · 2024-05-15
- HighRandox Clinical Chemistry Calibration Serum Recalled for Measurement Bias
FDA (Devices) · 2024-05-15
- HighMicroalbumin Calibrator Series Recalled for Negative Bias and Patient Result Misclassification
FDA (Devices) · 2024-04-24
- HighMicroalbumin Calibrator Series Recall Due to Measurement Accuracy Issue
FDA (Devices) · 2024-04-24
Same hazard · calibration failure
See all →- ModeratePhosphorus reagent lots recalled because calibration may fail before expiration date
FDA (Devices) · 2025-10-15
- ModerateLactate test slides recalled over calibration failures delaying patient results
FDA (Devices) · 2025-09-24
- ModerateLactate slides in 18-slide cartridges recalled over calibration failures delaying results
FDA (Devices) · 2025-09-24
- ModerateCalcium test slides recalled after calibration failures delayed patient results
FDA (Devices) · 2025-08-27
- ModerateBeckman Coulter DxC 500 AU Chemistry Analyzer Software Calibration Error
FDA (Devices) · 2025-05-21